Webinar

Exploring the value of home visits in clinical trials, the benefits gained by both the patient and the sponsor

Published

Format: External webinar | Document type: Webinar

Exploring the value of home visits in clinical trials, the benefits gained by both the patient and the sponsor

Related categories: Analytical (technologies & services)

Study protocols are increasingly complex with the need for extensive data collection despite complicated drug regimes. Patients may be deterred from taking part in a trial by the need for frequent travel to a clinical sites and around 30% of patients drop out before study completion, leading to data loss, and potential approval delays.

The new model for Direct to/from Patient and home health care allows visits to be conducted in a patient’s home which improves engagement.

Featured speakers will explore the value of home visits in clinical trials, the benefits gained by both the patient and the sponsor, and how homecare can make a difference to patients’ ongoing participation, quality of life and comfort throughout the trial.

For more information visit www.marken.com

Watch Now

Speakers

Kimberly Finn Kimberly Finn VP Global Homecare & DTP US Services
Marken

Paddy Hanlon Paddy Hanlon VP Global Key Accounts
Marken

Jennifer Fenwick Jennifer Fenwick Director, Project Management, Americas
Marken

Related resources from Marken: Global Life Science Supply Chain Solutions

Supplier info centre